Differentiation Capacity of Human Mesenchymal Stem Cells into Keratocyte Lineage
Open Access
- 1 July 2019
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 60 (8) , 3013-3023
Abstract
Mesenchymal stem cells (MSCs) have been extensively studied for their capacity to enhance wound healing and represent a promising research field for generating cell therapies for corneal scars. In the present study, we investigated MSCs from different tissues and their potential to differentiate toward corneal keratocytes. Adipose-derived stem cells, bone marrow MSCs, umbilical cord stem cells, and corneal stromal stem cells (CSSCs) were characterized by their expression of surface markers CD105, CD90, and CD73, and their multilineage differentiation capacity into adipocytes, osteoblasts, and chondrocytes. MSCs were also evaluated for their potential to differentiate toward keratocytes, and for upregulation of the anti-inflammatory protein TNFα-stimulated gene-6 (TNFAIP6) after simulation by IFN-γ and TNF-α. Keratocyte lineage induction was achieved in all MSCs as indicated by the upregulated expression of keratocyte markers, including keratocan, lumican, and carbohydrate sulfotransferase. TNFAIP6 response to inflammatory stimulation was observed only in CSSCs; increasing by 3-fold compared with the control (P < 0.05). Based on our findings, CSSCs appeared to have the greatest differentiation potential toward the keratocyte lineage and the greatest anti-inflammatory properties in vitro.Keywords
This publication has 75 references indexed in Scilit:
- Umbilical cord blood banking: an updateJournal of Assisted Reproduction and Genetics, 2011
- Chondrogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells: Tips and Tricks2011
- Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injuryProceedings of the National Academy of Sciences, 2010
- Cell Therapy of Congenital Corneal Diseases with Umbilical Mesenchymal Stem Cells: Lumican Null MicePLOS ONE, 2010
- Isolation and Animal Serum Free Expansion of Human Umbilical Cord Derived Mesenchymal Stromal Cells (MSCs) and Endothelial Colony Forming Progenitor Cells (ECFCs)Journal of Visualized Experiments, 2009
- Stem Cell Therapy Restores Transparency to Defective Murine CorneasStem Cells, 2009
- Secretion and Organization of a Cornea-like Tissue In Vitro by Stem Cells from Human Corneal StromaInvestigative Ophthalmology & Visual Science, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The keratocyte: Corneal stromal cell with variable repair phenotypesThe International Journal of Biochemistry & Cell Biology, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001